Hepatitis C virus infection in the Maghreb region

Journal of Medical Virology

Volumn 85, Issue 9, 2013, Pages 1542-1549

  Ezzikouri, Sayeh ^a   Pineau, Pascal ^b   Benjelloun, Soumaya ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b INSTITUT PASTEUR   (France)

Author keywords

Genotype; HCV; North Africa; Prevalence; Public health

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ALGERIA; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DATA BASE; EGYPT; ENDOSCOPIC SURGERY; GENOTYPE; HEALTH CARE PERSONNEL; HEMODIALYSIS; HEPATITIS C; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYGIENE; INCIDENCE; INTRAVENOUS DRUG ABUSE; LIBYAN ARAB JAMAHIRIYA; MALPRACTICE; MAURITANIA; MIXED INFECTION; MOROCCO; NEEDLESTICK INJURY; OCCUPATIONAL EXPOSURE; POPULATION; PREVALENCE; RISK FACTOR; SEROCONVERSION; SEROPREVALENCE; SEXUAL BEHAVIOR; STUDY DESIGN; TUNISIA; VIRUS STRAIN; VIRUS TRANSMISSION;

GENOTYPE; HCV; NORTH AFRICA; PREVALENCE; PUBLIC HEALTH;

AFRICA, NORTHERN; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; PREVALENCE;

HEPATITIS C VIRUS;

EID: 84880324916     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23643     Document Type: Article

References (67)

1. Alter H. 2006. Viral hepatitis. Hepatology 43:S230-S234.
2. Aqodad N, Lahbabi M, Elyousfi M, Mellouki I, Benajah D, Elabkari M, Ibrahimi A. 2011. Prevalence of VHC-Ab and HBsAg among blood donors in Guelmim in the south of Morocco. Hepatol Int 96:1936-2533.
3. Ayed K, Gorgi Y, Ben Abdallah T, Aouadi H, Jendoubi-Ayed S, Sfar I, Makni H. 2003. Hepatitis C virus infection in hemodialysis patients from Tunisia: National survey by serologic and molecular methods. Transplant Proc 35:2573-2575.
4. Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F. 1995. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria. Bull Soc Pathol Exot 88:225-228.
5. Bahadi A, Maoujoud O, Hassani K, Akhmouch I, Doblali T, El Allam M, Benyahia M, Elkabaj D, Mrani S, Oualim Z. 2011. L'hépatite C virale en hémodialyse: étude multicentrique ambispective de séroconversion et de prévalene. Néphrologie Thérapeutique 7:399-406.
6. Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AE, Mestiri H, Benazzouz M, Khalfallah T, Afifi R, Elkihal L, Berkane S, Marchio A, Debzi N, Dejean A, Pineau P, Triki H, Benjelloun S. 2011. First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol 3:24-30.
7. Bari A, Akhtar S, Rahbar MH, Luby SP. 2001. Risk factors for hepatitis C virus infection in male adults in Rawalpindi, Islamabad. Pakistan Trop Med Int Health 6:732-738.
8. Beghdadli B, Ghomari O, Taleb M, Belhaj Z, Belabed A, Kandouci AK, Fanello S. 2009. Personnel at risk for occupational blood exposure in a university hospital in West Algeria. Sante Publique 21:253-256.
9. Belbacha I, Cherkaoui I, Akrim M, Dooley KE, El Aouad R. 2011. Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco. East Mediterr Health J 17:911-919.
10. Belhadj N, Houissa F, Elloumi H, Ouakaa A, Gargouri D, Romani M, Kilani A, Kochlef A, Kharrat J, Ghorbel A. 2008. Virological response of Tunisians patients treated by peginterferon plus ribavirin for chronic hepatitis C: A preliminary study. Tunis Med 86:341-345.
11. Belhadj N, Houissa F, Elloumi H, Ouakaa A, Gargouri D, Romani M, Kilani A, Kochlef A, Kharrat J, Ghorbel A, Ben Alaya Bouafif N, Triki H, Mejri S, Bahri O, Chlif S, Bettaib J, Héchmi S, Dellagi K, Ben Salah A. 2007. A case control study to assess risk factors for hepatitis C among a general population in a highly endemic area of northwest Tunisia. Arch Inst Pasteur Tunis 84:21-27.
12. Ben Alaya Bouafif N, Triki H, Mejri S, Bahri O, Chlif S, Bettaib J, Héchmi S, Dellagi K, Ben Salah A. 2007. A case control study to assess risk factors for hepatitis C among a general population in a highly endemic area of northwest Tunisia. Arch Inst Pasteur Tunis 84:21-27.
13. Ben Moussa M, Barguellil F, Bouziani A, Amor A. 2003. Comparison of two hepatitis C virus typing assays in a Tunisian population. Ann Biol Clin (Paris) 61:234-238.
14. Benani A, El-Turk J, Benjelloun S, Sekkat S, Nadifi S, Hda N, Benslimane A. 1997. HCV genotypes in Morocco. J Med Virol 52:396-398.
15. Benjelloun S, Bahbouhi B, Sekkat S, Bennani A, Hda N, Benslimane A. 1996. Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups. Res Virol 147:247-255.
16. Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M. 2009. Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction. Pathol Biol (Paris) 57:368-372.
17. Berkane S. 2009. French Luncheon comment prendre en charge les patient's atteints d'hépatite C avec les médicaments disponibles en Algérie, 2009.
18. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N. 2005. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca. Nephrol Ther 1:274-284.
19. Brahim I, Akil A, Mtairag ElM, Pouillot R, Malki AE, Nadir S, Alaoui R, Njouom R, Pineau P, Ezzikouri S, Benjelloun S. 2012. Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades. Arch Virol 157:515-520.
20. Candan F, Alagözlü H, Poyraz O, Sümer H. 2002. Prevalence of hepatitis B and C virus infection in barbers in the Sivas region of Turkey. Occup Med 52:31-34.
21. Chiaramonte M, Pupo A, Menegon T, Baldo V, Malatesta R, Trivello R. 1998. HBV and HCV infection among non-European union immigrants in north-east Italy. Epidemiol Infect 121:179-183.
22. Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM. 2002. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Med J 23:1356-1360.
23. Djebbi A, Triki H, Bahri O, Cheikh I, Sadraoui A, Ben Ammar A, Dellagi K. 2003. Genotypes of hepatitis C virus circulating in Tunisia. Epidemiol Infect 130:501-505.
24. El-Kafrawy SA, Abdel-Hamid M, El-Daly M, Nada O, Ismail A, Ezzat S, Abdel-Latif S, Abdel-Hamid A, Shields PG, Loffredo C. 2005. P53 mutations in hepatocellular carcinoma patients in Egypt. Int J Hyg Environ Health 208:263-270.
25. el-Zayadi AR, Badran HM, Barakat EM, Attia Mel D, Shawky S, Mohamed MK, Selim O, Saeid A. 2005. Hepatocellular carcinoma in Egypt: A single center study over a decade. World J Gastroenterol 11:5193-5198.
26. El Annnaz H, Arrouchi H, Haoudi F, Doblali T, Belefquih B, Tagajdid R, Touil N, Mrani S. 2011. Les co-infections VIH-VHC et VIH-VHB à l′HMIMV de Rabat.
27. El Far MA, Atwa MA, Yahya RS, El Basuni MA. 2006. Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt. Clin Chem Lab Med 44:653-656.
28. ELahmer O, Zorgani A, Abudher A, Ziglam H. 2012. Prevalence of human immunodeciency virus, hepatitis B virus, hepatitis C virus among prison inmates, western Libya. The 22nd Annual European Congress of Clinical Microbiology and Infectious Diseases.
29. ELasifer HA, Agnnyia YM, ALagi BA, Daw MA. 2010. Epidemiological manifestations of hepatitis C virus genotypes and its assoiation with potential risk fators among Libyan patients. Virol J 7:317.
30. Elzouki AN. 2007. Hepatitis B, C, and HIV infection in Libya Libyan. J Infect Dis 1:132-133.
31. Gorgi Y, Yalaoui S, Ben Nejma HL, Azzouz MM, Hsairi M, Ben Khelifa H, Ayed K. 1998. Detection of hepatitis C virus in the general population of Tunisia. Bull Soc Pathol Exot 91:177.
32. Guerra J, Garenne M, Mohamed MK, Fontanet A. 2012. HCV burden of infection in Egypt: Results from a nationwide survey. J Viral Hepat 19:560-567.
33. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Anwar W, Strickland GT, Fix AD, Sallam I. 2001. Hepatitis C virus infection in a community in the Nile delta: Risk factors for seropositivity. Hepatology 33:248-253.
34. Hannachi N, Boughammoura L, Marzouk M, Tfifha M, Khlif A, Soussi S, Skouri H, Boukadida J. 2011. Viral infection risk in polytransfused adults: Seroprevalence of seven viruses in central Tunisia. Bull Soc Pathol Exot 104:220-225.
35. Hassan MM, Frome A, Patt YZ, El-Serag HB. 2002. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 35:266-269.
36. Hatira SA, Yacoub-Jemni S, Houissa B, Kaabi H, Zaeir M, Kortas M, Ghachem L. 2000. Hepatitis C virus antibodies in 34, 130 blood donors in Tunisian Sahel. Tunis Med 78:101-105.
37. Hemminki K, Mousavi SM, Brandt A, Ji J, Sundquist J. 2010. Liver and gallbladder cancer in immigrants to Sweden. Eur J Cancer 46:926-931.
38. Hooshyar D, Napravnik S, Miller WC, Eron JJ, Jr. 2006. Effect of hepatitis C coinfection on discontinuation and modification of initial HAART in primary HIV care. AIDS 20:575-583.
39. IARC Monographs. 1987. Overall evaluations of carcinogenicity. An updating of IARC monographs. Lyon: IARC Press. pp 1-42.
40. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G. 2006. A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat 13:775-782.
41. Kilani B, Ammari L, Marrakchi C, Letaief A, Chakroun M, Ben Jemaa M, Ben Aissa HT, Kanoun F, Ben Chaabene T. 2007. Seroepidemiology of HCV-HIV coinfection in Tunisia. Tunis Med 85:121-123.
42. Lahlou Amine I, Zouhair S, Chegri M, L'Kassmi H. 2010. Seroprevalence of anti-HCV in patients of the military hospital Moulay Ismail (Meknes, Morocco): Data analysis of the medical biology laboratory (2002-2005). Bull Soc Pathol Exot 103:255-258.
43. Langar H, Triki H, Gouider E, Bahri O, Djebbi A, Sadraoui A, Hafsia A, Hafsia R. 2005. Blood-transmitted viral infections among haemophiliacs in Tunisia. Transfus Clin Biol 12:301-305.
44. Lo BB, Meymouna M, Boulahi MA, Tew M, Sow A, Ba A, Sow MB. 1999. Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania. Bull Soc Pathol Exot 92:83-84.
45. Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Chen CH. 2006. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 119:1946-1952.
46. Maaref F, Kilani B, Ammari L, Ben Othman A, Zribi M, Fendri C, Masmoudi A. 2011. Prevalence of hepatitis G, B, and C virus infections among positive HIV population in a Tunisian hospital, La Rabta, Tunis. Pathol Biol (Paris) 59:213-216.
47. Mariano A, Mele A, Tosti ME, Parlato A, Gallo G, Ragni P, Zotti C, Lopalco P, Pompa MG, Graziani GTS. 2004. Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. J Med Virol 74:216-220.
48. Mejri S, Mhalla S, Ben Yahia A, Triki H. 2012. Molecular and phylogenetic analyses of Tunisian hepatitis C virus strains subtype 1b. Ann Biol Clin (Paris) 70:707-716.
49. Mejri S, Salah AB, Triki H, Alaya NB, Djebbi A, Dellagi K. 2005. Contrasting patterns of hepatitis C virus infection in two regions from Tunisia. J Med Virol 76:185-193.
50. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, Galanti C, Bernacchia R, Ferraro P. 1995. Beauty treatments and risk of parenterally transmitted hepatitis: Results from the hepatitis surveillance system in Italy. Scand J Infect Dis 27:441-444.
51. Ministère de la Santé, République de Mauritanie. 2011. Rapport d'analyse de situation du secteur de santé, Processus d'élaboration du plan national de dévelopement sanitaire 2012-2020.
52. Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6:e1000097.
53. National Travel Health Network, Centre, Country Information, Algeria, Tunisia, Morocco. 2009.
54. Oliveira AC, Focaccia R. 2010. Survey of hepatitis B and C infection control: Procedures at manicure and pedicure facilities in São Paulo, Brazil. Braz J Infect Dis 14:502-507.
55. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
56. Perz JF, Alter MJ. 2006. The coming wave of HCV-related liver disease: Dilemmas and challenges. J Hepatol 44:441-443.
57. Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, Afifi R, Elkihal L, Khalfallah MT, Mestiri H, Tebbal S, Berkane S, Debzi N, Triki H, Dejean A, Iguer F, Bahri O, Essaid El Feydi AE, Benjelloun S. 2007. Genomic stability prevails in north-African hepatocellular carcinomas. Dig Liver Dis 39:671-677.
58. Ribes J, Cleries R, Rubio A, Hernandez JM, Mazzara R, Madoz P, Casanovas T, Casanova A, Gallen M, Rodriguez C, Moreno V, Bosch FX. 2006. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 Years of follow-up. Int J Cancer 119:687-694.
59. Roudot-Thoraval F, Deforges L, Girollet PP, Maria B, Milliez J, Pathier D, Duval J, Dhumeaux D. 1992. Prevalence of hepatitis C virus antibodies (tests ELISA 2 and RIBA 2) in a population of pregnant women in France. Gastroenterol Clin Biol 16:255-259.
60. Saleh MG, Pereira LM, Tibbs CJ, Ziu M, al-Fituri MO, Williams R, McFarlane IG. 1994. High prevalence of hepatitis C virus in the normal Libyan population. Trans R Soc Trop Med Hyg 88:292-294.
61. Sekkat S, Kamal N, Benali B, Fellah H, Amazian K, Bourquia A, El Kholti A, Benslimane A. 2008. Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco. Nephrol Ther 4:105-110.
62. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
63. Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD. 2008. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis 47:1468-1475.
64. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, Hmida S, Dhahri R, Dellagi K. 1997. Seroepidemiology of hepatitis B, C, and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91:11-14.
65. Yerly S, Quadri R, Negro F, Barbe KP, Cheseaux JJ, Burgisser P, Siegrist CA, Perrin L. 2001. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis 184:369-372.
66. Zahraoui-Mehadji M, Zahraoui Baakrim M, Laraqui S, Laraqui O, El Kabouss Y, Verger C, Caubet A, Laraqui CH. 2004. Risque infectieux lié au sang chez les coiffeurs-barbiers traditionnels et leurs clients au Maroc. Cahiers Santé 14:211-216.
67. Zemouli N. Génotypes du Virus de l'hépatite C: Expérience du CHU Mustapha d'Alger, Alger. 2010.